Elicio Therapeutics, Inc.

ELTXReported to SECin USCIK 0001601485Filings at SEC EDGAR

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 11. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

5 of 11
Form 4 lines at Elicio Therapeutics, Inc., most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
Chudnovsky Yekaterina—Awardnothing paid21,750 sharesSep 2, 2026Chudnovsky Yekaterinanothing paidAward · Sep 2Award21,750Sep 2, 2026
Ashe Carol Gail—Awardnothing paid21,750 sharesSep 2, 2026Ashe Carol Gailnothing paidAward · Sep 2Award21,750Sep 2, 2026
Nissenson Allen—Awardnothing paid21,750 sharesSep 2, 2026Nissenson Allennothing paidAward · Sep 2Award21,750Sep 2, 2026
Venkatesan Jay—Awardnothing paid21,750 sharesSep 2, 2026Venkatesan Jaynothing paidAward · Sep 2Award21,750Sep 2, 2026
WILSON KAREN J—Awardnothing paid21,750 sharesSep 2, 2026WILSON KAREN Jnothing paidAward · Sep 2Award21,750Sep 2, 2026